Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OLP-1002 by OliPass for Osteoarthritis Pain: Likelihood of Approval
OLP-1002 is under clinical development by OliPass and currently in Phase II for Osteoarthritis Pain. According to GlobalData, Phase II...